Johnson & Johnson Consumer Inc.

Johnson & Johnson Consumer Companies, Inc.

Kimberly A Capone

Russel M Walters

Frank C Sun

Elizabeth Bruning

Euen T Ekman-Gunn

Anthony Robert Geonnotti, Iii

Frank J Kirchner

Michael D Southall

Ali Fassih

Davide Miksa

Diana Roshek Johnson

Barry Setiawan

Liliam A Moreira

Julie Marie Bianchini

Alpana Oak

Prithwiraj Maitra

Janeta Nikolovski

Delores M Santora

Manpreet Randhawa

Euen Thomas Graham Ekman Gunn

Georgios N Stamatas

James E Hauschild

Selina Moses

Kelly A Lewis

Kelly A Dunn

Lorena Telofski

Lisa Renee Gandolfi

Fang Liu-Walsh

This invention relates to methods and compositions for inhibiting the transmission of enveloped viruses, which entails applying a composition containing a high molecular weight hydrophobically-modified polymer to an infectable or ingestible surface that may contain viruses and wherein said anti-viral composition comprises less than about 9% by weight of surfactant having an HLB greater than about 12.

Methods and compositions for inhibiting enveloped viruses using high molecular weight hydrophobically modified alkali swellable emulsion polymers and surfactant

This invention relates to methods and compositions for inhibiting the transmission of enveloped viruses, which entails applying a composition containing a high molecular weight hydrophobically-modified polymer to an infectable or ingestible surface that may contain viruses and wherein said anti-viral composition is substantially free of surfactant having an HLB greater than about 12.

Methods and compositions inhibiting enveloped viruses using high molecular weight hydrophobically modified alkali swellable emulsion polymers

This invention relates to methods and compositions for inhibiting the transmission of enveloped viruses, which entails applying a composition containing a low molecular weight hydrophobically-modified polymer to an infectable or ingestible surface that may contain viruses, wherein said compositions further comprise less than about 9% by weight of surfactant having an HLB of greater than 12.

Methods of inhibiting enveloped viruses using low molecular weight hydrophobically modified polymers

A method of selecting skin treatment regimens, ingredients and compositions that includes measuring the levels of particular small molecule metabolites on skin both before and after product application and testing for a change in small molecule metabolite levels is disclosed.

Method of selecting skin treatment regimens, ingredients and compositions

The present invention provides compositions, methods and kits for treating acne and other skin conditions influenced by, which combine administration of low levels of at least one C2 to C5 polycarboxylic acid and blue light to skin in need of treatment for such conditions.

Compositions and methods for treating skin conditions using light and polycarboxylic acids

The present invention provides a method of increasing the growth ofon skin, comprising topically applying to skin in need of treatment for eczema, acne, decreased moisturization, or other skin conditions associated with microbiota dysbiosis a composition comprising an extract ofand glycerin.

Topical composition containing glycerin and yeast extract

This invention relates to methods and compositions for degrading collagen in mammalian skin, thereby improving the appearance and/or reducing the size of a closed wound, which may be a scar or a keloid and cellulite or other conditions wherein excessive collagen is a problem.

Methods and compositions for improving appearance and formation of scar tissue

Growing community of inventors

Lambertville, NJ, United States of America

Kimberly A Capone